More than 300 exclusions from the Section 301 tariffs on imports from China, which had been scheduled to expire Dec. 31, are being extended through Sept. 30, 2023. Importers of covered goods (click here for full list) can utilize any of these exclusions for any product that meets the description in the exclusion regardless of whether they requested the exclusion.

Exclusions from the Section 301 tariffs on imports from China for 81 medical care products needed to address the COVID-19 pandemic were previously extended from Nov. 30 through Feb. 28, 2023.

In the meantime, the Office of the U.S. Trade Representative is accepting comments through Jan. 17 as part of a review of all Section 301 tariffs on imports from China. U.S. importers, manufacturers, retailers, and others that have been hammered by these tariffs should use this process to press the White House for relief. ST&R can assist in preparing and submitting comments to USTR; for more information, please contact Ned Steiner at (202) 730-4970 or via email.

In addition, efforts to ameliorate the impact of the Section 301 tariffs are continuing.

- ST&R is advocating for the renewal of all previously approved exclusions and the creation of a process allowing for new exclusion requests (for more information, please contact

- There are a number of proven and legitimate ways to effectively avoid the tariffs or limit their impact (click here for more information).

- Importers of List 3 and 4A goods from China can still preserve their rights to possible refunds of tariffs paid on such goods by joining an ongoing court case (for more information, or assistance filing a claim, please contact us at

Copyright © 2024 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.

ST&R: International Trade Law & Policy

Since 1977, we have set the standard for international trade lawyers and consultants, providing comprehensive and effective customs, import and export services to clients worldwide.

View Our Services 


Cookie Consent

We have updated our Privacy Policy relating to our use of cookies on our website and the sharing of information. By continuing to use our website or subscribe to our publications, you agree to the Privacy Policy and Terms & Conditions.